QualityStocksNewsBreaks Archives

TuesdayNov 28, 2023 11:48 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Tech Lowers Blood Glucose More Effectively than Branded GLP-1 drug Semaglutide Alone, Study Shows

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting additional positive interim results from its human pilot study evaluating DehydraTECH(TM) technology for the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially as Rybelsus(R). According to the report, DehydraTECH-powered semaglutide sustained lower levels of blood glucose from baseline including nearly 10 times lower after 24 hours as well as lower blood-glucose spikes after eating. The company noted that this was the first-ever DehydraTECH test with a “large molecule” drug. According to the report, the study was conducted by a prominent university research center comparing a single…

TuesdayNov 28, 2023 11:20 am

QualityStocksNewsBreaks – Astrotech Corporation (NASDAQ: ASTC) Unveils AgLAB MVP TM – a Game Changer for Cannabinoid Industry

Astrotech (NASDAQ: ASTC), together with its wholly owned subsidiary, AgLAB Inc., announced the presentation of the AgLAB Maximum Value Process TM (“MVP TM”) at MJBizCon. According to the announcement, the revolutionary process control system has been proven to increase the potency of ending-weight yields and increase revenue by an average of 32%. Utilizing AgLAB’s proprietary mass spectrometer and testing method, MVP TM provides real-time data and feedback, allowing distillers to adjust the parameters (temperature, feed-rate, pressure) and optimize the quality and quantity of each batch of oil. “We are proud to introduce the AgLAB MVP TM, a breakthrough technology that…

TuesdayNov 28, 2023 11:07 am

QualityStocksNewsBreaks — Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Reports Discovery of ‘Unprecedented’ High-Grade Mineralized Zone

Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF) (FSE: A0I0), a Canadian company in the rare earth element and uranium sectors, has discovered an unprecedented high-grade mineralized zone at its PCH Ionic Clay project in Brazil. According to the announcement, the discovery shows a total weighted average grade of 7,578 ppm or 0.76% total rare earth oxide across 10 reverse circulation (“RC”) drill holes. This information is the result of the further delineation of the SW Extension Zone, a significant high-grade rare earth elements (“REE”) mineralized zone located in the southwest corner of the Target IV zone of the project.…

TuesdayNov 28, 2023 10:59 am

QualityStocksNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Announces Soft Bait Fertility Solution in California Ace Hardware Stores, Prices Public Offering

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, has launched its Evolve(TM) Soft Bait product at Ace Hardware franchise locations in California; the franchise also began selling SenesTech’s Isolate(TM) bait system. According to the announcement, this is the first time a traditional retail store has carried SenesTech rodent fertility control solutions. Evolve is the first and only soft bait product featuring breakthrough, next-generation technology designed to decrease rodent populations through nonlethal methods. “California-based Scarborough Ace Hardware, as well as Scarborough Home and Garden, are the first retail outlets to commit to SenesTech's line,” said SenesTech president and…

MondayNov 27, 2023 2:07 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Shown to Improve Oral Performance of GLP-1 Drug in Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced positive interim results from a human pilot study currently underway evaluating DehydraTECH(TM) technology for the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide, which is available commercially in the branded product Rybelsus(R). A prominent university research center is performing the study, comparing a single 7 mg semaglutide dose of a Rybelsus tablet (“control”) to a matching dose from Rybelsus that had been compound formulated in capsule form using DehydraTECH processing technology enhancements (“DehydraTECH GLP-1”). According to the update, blood was examined by a third-party laboratory…

MondayNov 27, 2023 1:26 pm

QualityStocksNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) CEO Featured in ‘New to The Street’ Interview

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a leading Swiss-hosted secure and private communications platform, will be featured in a business guest interview on episode 533 of FMW Media’s “New to The Street” program. The episode will air on the FOX Business Network at 10:30 p.m. PT on Nov. 27, 2023. The interview, “Sekur Privacy & Sekur Security – Weekly Hack Segment,” will feature Sekur’s CEO and internet privacy expert, Alain Ghiai, as he joins TV co-host and multi-media journalist Ana Berry to discuss the hacking of ICBC (Industrial and Commercial Bank of China Limited), the largest bank…

MondayNov 27, 2023 1:16 pm

QualityStocksNewsBreaks – Safety Shot (NASDAQ: SHOT) Begins Scientific Study, Hires Securities Litigation Attorney

Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, has begun a double-blind, placebo-controlled clinical trial designed to study and evaluate the effects of its flagship product, Safety Shot, on blood and breath alcohol levels. According to the announcement, the company is committed to the scientific development of Safety Shot, the first patented beverage designed to reduce blood alcohol content and boost clarity in order to help people feel better faster. The exclusive nutraceutical functional beverage accelerates the body’s breakdown of alcohol while aiding in recovery and rehydration. The company anticipated having topline data by first quarter 2024. “Recent…

MondayNov 27, 2023 12:45 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Issues Update on CBP Application for Class 1 EV Cargo Vans

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that the company and Rapid Response Defense Systems (“RRDS”) have filed responses for final ruling and compliance by the U.S. Customs and Border Protection (“CBP”) application for Mullen’s Class 1 EV cargo van. In March 2023, the companies announced a partnership with RRDS, one of the country’s leading small business federal contractors, selecting Mullen as exclusive provider of Class 1 EV cargo vans. On behalf of Mullen, RRDS filed the Ruling Request Application, which details the substantial transformation Mullen completed for the Class 1 EV cargo van to…

MondayNov 27, 2023 12:36 pm

QualityStocksNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Closes on Public Offering Reaching Estimated $7M

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, has closed its previously announced public offering. The offering was comprised of 5,384,615 shares of common stock (or common stock equivalents in lieu thereof) and warrants; the shares were offered at $1.30 per share (or common stock equivalent in lieu thereof) and accompanying warrant. According to the announcement, the warrants also had an exercise price of $1.30 per share, as well as being exercisable immediately upon issuance; the warrants will expire five years after the initial exercise date. The company noted that total gross proceeds for the…

WednesdayNov 22, 2023 3:21 pm

QualityStocksNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Featured Guest in Recent Proactive Interview

Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, was featured in a recent Proactive interview. Mark Dybul, CEO of Renovaro, joined host Steve Darling to talk about the company and its achievements and potential. Specifically, the two talked about the company’s recent signing of a definitive agreement to merge with GEDiCube, a United-Kingdom-based medical artificial intelligence (“AI”) company renowned for its contributions to the early detection and remission of cancer, as well as expedited drug discovery. During the interview, Dybul discussed the plan to rebrand GEDiCube…

Site Search

Company Search

Category: QualityStocksNewsBreaks